Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.22% |
| Dec 31, 2025 | 18.12% |
| Sep 30, 2025 | 1.30% |
| Jun 30, 2025 | -8.16% |
| Mar 31, 2025 | 1.43% |
| Dec 31, 2024 | 27.46% |
| Sep 30, 2024 | 7.57% |
| Jun 30, 2024 | 75.27% |
| Mar 31, 2024 | 36.60% |
| Dec 31, 2023 | 155.39% |
| Sep 30, 2023 | -181.47% |
| Jun 30, 2023 | 27.71% |
| Mar 31, 2023 | 16.08% |
| Dec 31, 2022 | 11.97% |
| Sep 30, 2022 | 5.22% |
| Jun 30, 2022 | 63.27% |
| Mar 31, 2022 | 42.24% |
| Dec 31, 2021 | -9.88% |
| Sep 30, 2021 | -15.20% |
| Jun 30, 2021 | 58.96% |